OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Applying high-dimensional single-cell technologies to the analysis of cancer immunotherapy
Satyen H. Gohil, J. Bryan Iorgulescu, David A. Braun, et al.
Nature Reviews Clinical Oncology (2020) Vol. 18, Iss. 4, pp. 244-256
Open Access | Times Cited: 196

Showing 1-25 of 196 citing articles:

The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
Karin E. de Visser, Johanna A. Joyce
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 374-403
Open Access | Times Cited: 1233

Therapeutic Targeting of the Tumor Microenvironment
Leire Bejarano, Marta Joana Costa Jordão, Johanna A. Joyce
Cancer Discovery (2021) Vol. 11, Iss. 4, pp. 933-959
Open Access | Times Cited: 998

Applications of single-cell sequencing in cancer research: progress and perspectives
Yalan Lei, Rong Tang, Jin Xu, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 320

Dynamics and specificities of T cells in cancer immunotherapy
Giacomo Oliveira, Catherine J. Wu
Nature reviews. Cancer (2023) Vol. 23, Iss. 5, pp. 295-316
Closed Access | Times Cited: 195

Artificial intelligence-based multi-omics analysis fuels cancer precision medicine
Xiujing He, Xiaowei Liu, Fengli Zuo, et al.
Seminars in Cancer Biology (2022) Vol. 88, pp. 187-200
Open Access | Times Cited: 123

Targeting galectin-driven regulatory circuits in cancer and fibrosis
Karina V. Mariño, Alejandro J. Cagnoni, Diego O. Croci, et al.
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 4, pp. 295-316
Open Access | Times Cited: 123

Reshaping the systemic tumor immune environment (STIE) and tumor immune microenvironment (TIME) to enhance immunotherapy efficacy in solid tumors
Liangliang Xu, Chang Zou, Shanshan Zhang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 105

Genomic profiling for clinical decision making in lymphoid neoplasms
Laurence de Leval, Ash A. Alizadeh, P. Leif Bergsagel, et al.
Blood (2022) Vol. 140, Iss. 21, pp. 2193-2227
Open Access | Times Cited: 101

Tumor microenvironment signaling and therapeutics in cancer progression
Anshika Goenka, Fatima Khan, Bhupender Verma, et al.
Cancer Communications (2023) Vol. 43, Iss. 5, pp. 525-561
Open Access | Times Cited: 101

Signaling pathways and targeted therapies in lung squamous cell carcinoma: mechanisms and clinical trials
Zhenyi Niu, Runsen Jin, Yan Zhang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 84

Biomarkers for immunotherapy of hepatocellular carcinoma
Tim F. Greten, Augusto Villanueva, Firouzeh Korangy, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 11, pp. 780-798
Closed Access | Times Cited: 81

Harnessing big data to characterize immune-related adverse events
Ying Jing, Jingwen Yang, Douglas B. Johnson, et al.
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 4, pp. 269-280
Closed Access | Times Cited: 73

Spatial maps of T cell receptors and transcriptomes reveal distinct immune niches and interactions in the adaptive immune response
Sophia Liu, J. Bryan Iorgulescu, Shuqiang Li, et al.
Immunity (2022) Vol. 55, Iss. 10, pp. 1940-1952.e5
Open Access | Times Cited: 67

Cell–cell communication inference and analysis in the tumour microenvironments from single-cell transcriptomics: data resources and computational strategies
Lihong Peng, Feixiang Wang, Zhao Wang, et al.
Briefings in Bioinformatics (2022) Vol. 23, Iss. 4
Closed Access | Times Cited: 64

Advancing CAR T cell therapy through the use of multidimensional omics data
Jingwen Yang, Yamei Chen, Ying Jing, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 4, pp. 211-228
Closed Access | Times Cited: 63

Recent advances in mRNA cancer vaccines: meeting challenges and embracing opportunities
Bolin Wang, Jinli Pei, Shengnan Xu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 49

Phenomic Studies on Diseases: Potential and Challenges
Weihai Ying
Phenomics (2023) Vol. 3, Iss. 3, pp. 285-299
Open Access | Times Cited: 45

Cancer stem cells: advances in knowledge and implications for cancer therapy
Xianjing Chu, Wentao Tian, Jiaoyang Ning, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 45

Responsive biomaterials: optimizing control of cancer immunotherapy
Lulu Xue, Ajay S. Thatte, David Mai, et al.
Nature Reviews Materials (2023) Vol. 9, Iss. 2, pp. 100-118
Closed Access | Times Cited: 40

T-cell infiltration and its regulatory mechanisms in cancers: insights at single-cell resolution
Wenhui Yang, Shimao Liu, Mengyun Mao, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 18

Exploring cellular diversity in lung adenocarcinoma epithelium: Advancing prognostic methods and immunotherapeutic strategies
Lianmin Zhang, Yanan Cui, Jie Mei, et al.
Cell Proliferation (2024) Vol. 57, Iss. 11
Open Access | Times Cited: 16

Profiling cell identity and tissue architecture with single-cell and spatial transcriptomics
Gunsagar S. Gulati, Jeremy Philip D’Silva, Yunhe Liu, et al.
Nature Reviews Molecular Cell Biology (2024) Vol. 26, Iss. 1, pp. 11-31
Closed Access | Times Cited: 16

Metformin, Macrophage Dysfunction and Atherosclerosis
Xiaojun Feng, Wenxu Chen, Xiayun Ni, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 85

Page 1 - Next Page

Scroll to top